Treatment of encephalitis in children with centrophenoxin as a supplementary drug.
D000085:Acetates / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002697:Chloral Hydrate / Q000627:therapeutic use; D004357:Drug Synergism; D004660:Encephalitis / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006429:Hemiplegia / Q000150:complications; D006801:Humans; D007223:Infant; D008297:Male; D002504:Meclofenoxate / Q000009:adverse effects / Q000627:therapeutic use; D009461:Neurologic Manifestations; D010634:Phenobarbital / Q000627:therapeutic use
D000085:Acetates; D000900:Anti-Bacterial Agents; D000697:Central Nervous System Stimulants; D002697:Chloral Hydrate; D002504:Meclofenoxate; D010634:Phenobarbital